House bill · 119th Congress
H.R. 4605: End Prescription Drug Ads Now Act
Would ban prescription drug commercials aimed at the public, on television, radio, print and online.
Introduced October 7, 2025 by Rep. Elena Calderón [D-NY-12] · 1 cosponsors · Health
Introduced
A member formally files the measure.
In committee (current)
A committee studies it and can change it.
Passed one chamber
The originating chamber votes yes.
Passed both chambers
The other chamber passes the same text.
To the President
Signed, vetoed, or left to become law.
This measure is with House committees. Most measures never leave this stage.
Plain language explanation
AI generated, reviewed by a human editorH.R. 4605 would prohibit prescription drug advertising directed at consumers on television, radio, print and online. Communications directed to licensed health care providers were exempted when the committee reported the bill. The committee ordered the bill reported on April 22, 2026 by a vote of 31 to 21, and it is on the Union Calendar awaiting a floor vote.
Not established in the record:
- Whether House leadership will schedule a floor vote this session.
What this measure does
Drug companies could no longer run prescription drug ads aimed at the public. They could still talk to doctors. The Federal Trade Commission would enforce the ban, starting a year and a half after the bill becomes law.
Reported in House · May 8, 2026
Cost estimate
Ten-year net effect of $1.2 billion in savings. CBO estimates the bill would reduce direct spending by 1,240,000,000 dollars over the 2027 to 2036 period, mostly through lower prescription drug utilization.
What this means where you live
Congress.gov holds the text, actions and votes for H.R. 4605. District level effects and your representative's position are held by HouseConnect.
Reading a measure
Start with the plain-language summary and the status tracker. Every statement links back to the official action or bill text it came from, so you can check anything you read.
Glossary of legislative terms